John N Whitaker

Multiple Sclerosis
Mult Scler 2002 8: 1. [PDF]  

P K Coyle and H-P Hartung

Use of interferon beta in multiple sclerosis: rationale for early treatment and evidence for dose- and frequency-dependent effects on clinical response
Mult Scler 2002 8: 2-9. [Abstract] [PDF] [References]  

C Liu and L D Blumhardt

Randomized, double-blind, placebo-controlled study of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis: a categorical disability trend analysis
Mult Scler 2002 8: 10-14. [Abstract] [PDF] [References]  

J Reeß, J Haas, K Gabriel, A Fuhlrott, and M Fiola

Both paracetamol and ibuprofen are equally effective in managing flu-like symptoms in relapsing-remitting multiple sclerosis patients during interferon beta-1a (AVONEX®) therapy
Mult Scler 2002 8: 15-18. [Abstract] [PDF] [References]  

M S Freedman, L D Blumhardt, B Brochet, G Comi, J H Noseworthy, M Sandberg-Wollheim, and P Soelberg Sørensen Paris Workshop Group

International consensus statement on the use of disease-modifying agents in multiple sclerosis
Mult Scler 2002 8: 19-23. [Abstract] [PDF] [References]  

J A Frank, N Richert, B Lewis, C Bash, T Howard, R Civil, R Stone, J Eaton, H McFarland, and T Leist

A pilot study of recombinant insulin-like growth factor-1 in seven multiple sclerosis patients
Mult Scler 2002 8: 24-29. [Abstract] [PDF] [References]  

G Gillson, T L Richards, R B Smith, and J V Wright

A double-blind pilot study of the effect of Prokarin^TM on fatigue in multiple sclerosis
Mult Scler 2002 8: 30-35. [Abstract] [PDF] [References]  

M Messmer Uccelli, M A Battaglia, P Zagami, and C Solaro

The interdisciplinary approach to the treatment of multiple sclerosis patients in Italy: an aspiration or a reality?
Mult Scler 2002 8: 36-39. [Abstract] [PDF] [References]  

H F McFarland, F Barkhof, J Antel, and D H Miller

The role of MRI as a surrogate outcome measure in multiple sclerosis
Mult Scler 2002 8: 40-51. [Abstract] [PDF] [References]  

M Rovaris, M Holtmannspötter, M A Rocca, G Iannucci, M Codella, B Viti, A Campi, G Comi, T A Yousry, and M Filippi

Contribution of cervical cord MRI and brain magnetization transfer imaging to the assessment of individual patients with multiple sclerosis: a preliminary study
Mult Scler 2002 8: 52-58. [Abstract] [PDF] [References]  

B Casanova, F Coret, C Valero, L Landete, A Pascual, and J J Vilchez

High clinical inflammatory activity prior to the development of secondary progression: a prospective 5-year follow-up study
Mult Scler 2002 8: 59-63. [Abstract] [PDF] [References]  

A HC van der Meijs, I L Tan, and F Barkhof

Incidence of enhancement of the trigeminal nerve on MRI in patients with multiple sclerosis
Mult Scler 2002 8: 64-67. [Abstract] [PDF] [References]  

Multiple Sclerosis: Online access
Mult Scler 2002 8: 68. [PDF]  

H F McFarland

The emerging role of MRI in multiple sclerosis and the new diagnostic criteria
Mult Scler 2002 8: 71-72. [PDF] [References]  

Platform Presentations
Mult Scler 2002 8: 73-80. [PDF]  

G PA Rice

The natural history of secondary progressive multiple sclerosis: observations from the London study group
Mult Scler 2002 8: 81-82. [PDF] [References]  

L P Weiner, N J Kachuck, W Gilmore, and B Lund

Immunological aspects of secondary progressive multiple sclerosis
Mult Scler 2002 8: 83-84. [PDF] [References]  

J S Wolinsky

MRI aspects of secondary progressive multiple sclerosis
Mult Scler 2002 8: 85-87. [PDF] [References]  

F D Lublin

Therapeutic approaches to secondary progressive multiple sclerosis
Mult Scler 2002 8: 88-90. [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.